K. Young, E. Regan, M. Han, S. Lutz, M. Ragland, P. Castaldi, G. Washko, M. Cho, M. Strand, D. Curran-Everett, T. Beaty, R. Bowler, E. Wan, D. Lynch, B. Make, E. Silverman, J. Crapo, J. Hokanson, G. Kinney
{"title":"慢性阻塞性肺病亚型具有独特的分布和不同的死亡风险。","authors":"K. Young, E. Regan, M. Han, S. Lutz, M. Ragland, P. Castaldi, G. Washko, M. Cho, M. Strand, D. Curran-Everett, T. Beaty, R. Bowler, E. Wan, D. Lynch, B. Make, E. Silverman, J. Crapo, J. Hokanson, G. Kinney","doi":"10.15326/jcopdf.6.5.2019.0150","DOIUrl":null,"url":null,"abstract":"Background\nPrevious attempts to explore the heterogeneity of chronic obstructive pulmonary disease (COPD) clustered individual patients using clinical, demographic, and disease features. We developed continuous multidimensional disease axes based on radiographic and spirometric variables that split into an airway-predominant axis and an emphysema-predominant axis.\n\n\nMethods\nThe COPD Genetic Epidemiology study (COPDGene®) is a cohort of current and former smokers, > 45 years, with at least 10 pack years of smoking history. Spirometry measures, blood pressure and body mass were directly measured. Mortality was assessed through continuing longitudinal follow-up and cause of death was adjudicated. Among 8157 COPDGene® participants with complete spirometry and computed tomography (CT) measures, the top 2 deciles of the airway-predominant and emphysema-predominant axes previously identified were used to categorize individuals into 3 groups having the highest risk for mortality using Cox proportional hazard ratios. These groups were also assessed for causal mortality. Biomarkers of COPD (fibrinogen, soluble receptor for advanced glycation end products [sRAGE], C-reactive protein [CRP], clara cell secretory protein [CC16], surfactant-D [SP-D]) were compared by group.\n\n\nFindings\nHigh-risk subtype classification was defined for 2638 COPDGene® participants who were in the highest 2 deciles of either the airway-predominant and/or emphysema-predominant axis (32% of the cohort). These high-risk participants fell into 3 groups: airway-predominant disease only (APD-only), emphysema-predominant disease only (EPD-only) and combined APD-EPD. There was 26% mortality for the APD-only group, 21% mortality for the EPD-only group, and 54% mortality for the combined APD-EPD group. The APD-only group (n=1007) was younger, had a lower forced expiratory volume in 1 second (FEV1) percent (%) predicted and a strong association with the preserved ratio-impaired spirometry (PRISm) quadrant. The EPD-only group (n=1006) showed a relatively higher FEV1 % predicted and included largely GOLD stage 0, 1 and 2 partipants. Individuals in each of the 3 high-risk groups were at greater risk for respiratory mortality, while those in the APD-only group were additionally at greater risk for cardiovascular mortality. Biomarker analysis demonstrated a significant association of the APD-only group with CRP, and sRAGE demonstrated greatest significance with both the EPD-only and the combined APD-EPD groups.\n\n\nInterpretation\nAmong current and former smokers, individuals in the highest 2 deciles for mortality risk on the airway-predominant axis and the emphysema-predominant axis have unique associations to spirometric patterns, different imaging characteristics, biomarkers and causal mortality.","PeriodicalId":10249,"journal":{"name":"Chronic obstructive pulmonary diseases","volume":"85 1","pages":"400-413"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"22","resultStr":"{\"title\":\"Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality.\",\"authors\":\"K. Young, E. Regan, M. Han, S. Lutz, M. Ragland, P. Castaldi, G. Washko, M. Cho, M. Strand, D. Curran-Everett, T. Beaty, R. Bowler, E. Wan, D. Lynch, B. Make, E. Silverman, J. Crapo, J. Hokanson, G. Kinney\",\"doi\":\"10.15326/jcopdf.6.5.2019.0150\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background\\nPrevious attempts to explore the heterogeneity of chronic obstructive pulmonary disease (COPD) clustered individual patients using clinical, demographic, and disease features. We developed continuous multidimensional disease axes based on radiographic and spirometric variables that split into an airway-predominant axis and an emphysema-predominant axis.\\n\\n\\nMethods\\nThe COPD Genetic Epidemiology study (COPDGene®) is a cohort of current and former smokers, > 45 years, with at least 10 pack years of smoking history. Spirometry measures, blood pressure and body mass were directly measured. Mortality was assessed through continuing longitudinal follow-up and cause of death was adjudicated. Among 8157 COPDGene® participants with complete spirometry and computed tomography (CT) measures, the top 2 deciles of the airway-predominant and emphysema-predominant axes previously identified were used to categorize individuals into 3 groups having the highest risk for mortality using Cox proportional hazard ratios. These groups were also assessed for causal mortality. Biomarkers of COPD (fibrinogen, soluble receptor for advanced glycation end products [sRAGE], C-reactive protein [CRP], clara cell secretory protein [CC16], surfactant-D [SP-D]) were compared by group.\\n\\n\\nFindings\\nHigh-risk subtype classification was defined for 2638 COPDGene® participants who were in the highest 2 deciles of either the airway-predominant and/or emphysema-predominant axis (32% of the cohort). These high-risk participants fell into 3 groups: airway-predominant disease only (APD-only), emphysema-predominant disease only (EPD-only) and combined APD-EPD. There was 26% mortality for the APD-only group, 21% mortality for the EPD-only group, and 54% mortality for the combined APD-EPD group. The APD-only group (n=1007) was younger, had a lower forced expiratory volume in 1 second (FEV1) percent (%) predicted and a strong association with the preserved ratio-impaired spirometry (PRISm) quadrant. The EPD-only group (n=1006) showed a relatively higher FEV1 % predicted and included largely GOLD stage 0, 1 and 2 partipants. Individuals in each of the 3 high-risk groups were at greater risk for respiratory mortality, while those in the APD-only group were additionally at greater risk for cardiovascular mortality. Biomarker analysis demonstrated a significant association of the APD-only group with CRP, and sRAGE demonstrated greatest significance with both the EPD-only and the combined APD-EPD groups.\\n\\n\\nInterpretation\\nAmong current and former smokers, individuals in the highest 2 deciles for mortality risk on the airway-predominant axis and the emphysema-predominant axis have unique associations to spirometric patterns, different imaging characteristics, biomarkers and causal mortality.\",\"PeriodicalId\":10249,\"journal\":{\"name\":\"Chronic obstructive pulmonary diseases\",\"volume\":\"85 1\",\"pages\":\"400-413\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"22\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chronic obstructive pulmonary diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15326/jcopdf.6.5.2019.0150\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic obstructive pulmonary diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15326/jcopdf.6.5.2019.0150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 22
摘要
背景:以往研究慢性阻塞性肺疾病(COPD)异质性的尝试使用临床、人口统计学和疾病特征对个体患者进行聚类。我们根据放射学和肺活量学变量开发了连续的多维疾病轴,分为气道主导轴和肺气肿主导轴。方法COPD遗传流行病学研究(COPDGene®)是一组年龄在45岁以上、吸烟史至少10包年的吸烟者和戒烟者。直接测量肺活量、血压和体重。通过持续的纵向随访评估死亡率,并确定死亡原因。在8157名具有完整肺活量测定和计算机断层扫描(CT)测量的COPDGene®参与者中,使用Cox比例风险比将先前确定的气道优势轴和肺气肿优势轴的前2十分位数将个体分为死亡风险最高的3组。对这些组的因果死亡率也进行了评估。各组COPD生物标志物(纤维蛋白原、晚期糖基化终产物可溶性受体[sRAGE]、c反应蛋白[CRP]、clara细胞分泌蛋白[CC16]、表面活性剂- d [SP-D])比较。发现2638名COPDGene®参与者(占队列的32%)处于气道显性轴和/或肺气肿显性轴的最高2十分位数,定义了高风险亚型分类。这些高风险参与者分为3组:仅气道显性疾病组(APD-only)、仅肺气肿显性疾病组(EPD-only)和APD-EPD联合组。单纯apd组死亡率为26%,单纯epd组死亡率为21%,APD-EPD联合组死亡率为54%。仅apd组(n=1007)更年轻,预测的1秒用力呼气量(FEV1)百分比(%)更低,与保留比率受损肺活量(PRISm)象限有很强的相关性。纯epd组(n=1006)显示出相对较高的FEV1 %预测,主要包括GOLD期0、1和2期参与者。3个高危组中的每一个人都有更高的呼吸死亡风险,而仅apd组的人心血管死亡风险更高。生物标志物分析显示APD-only组与CRP显著相关,而sRAGE在APD-only组和APD-EPD联合组中均表现出最大的相关性。在现在和以前的吸烟者中,在气道优势轴和肺气肿优势轴上死亡风险最高的2十分位数的个体与肺活量测量模式、不同的成像特征、生物标志物和因果死亡率具有独特的关联。
Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality.
Background
Previous attempts to explore the heterogeneity of chronic obstructive pulmonary disease (COPD) clustered individual patients using clinical, demographic, and disease features. We developed continuous multidimensional disease axes based on radiographic and spirometric variables that split into an airway-predominant axis and an emphysema-predominant axis.
Methods
The COPD Genetic Epidemiology study (COPDGene®) is a cohort of current and former smokers, > 45 years, with at least 10 pack years of smoking history. Spirometry measures, blood pressure and body mass were directly measured. Mortality was assessed through continuing longitudinal follow-up and cause of death was adjudicated. Among 8157 COPDGene® participants with complete spirometry and computed tomography (CT) measures, the top 2 deciles of the airway-predominant and emphysema-predominant axes previously identified were used to categorize individuals into 3 groups having the highest risk for mortality using Cox proportional hazard ratios. These groups were also assessed for causal mortality. Biomarkers of COPD (fibrinogen, soluble receptor for advanced glycation end products [sRAGE], C-reactive protein [CRP], clara cell secretory protein [CC16], surfactant-D [SP-D]) were compared by group.
Findings
High-risk subtype classification was defined for 2638 COPDGene® participants who were in the highest 2 deciles of either the airway-predominant and/or emphysema-predominant axis (32% of the cohort). These high-risk participants fell into 3 groups: airway-predominant disease only (APD-only), emphysema-predominant disease only (EPD-only) and combined APD-EPD. There was 26% mortality for the APD-only group, 21% mortality for the EPD-only group, and 54% mortality for the combined APD-EPD group. The APD-only group (n=1007) was younger, had a lower forced expiratory volume in 1 second (FEV1) percent (%) predicted and a strong association with the preserved ratio-impaired spirometry (PRISm) quadrant. The EPD-only group (n=1006) showed a relatively higher FEV1 % predicted and included largely GOLD stage 0, 1 and 2 partipants. Individuals in each of the 3 high-risk groups were at greater risk for respiratory mortality, while those in the APD-only group were additionally at greater risk for cardiovascular mortality. Biomarker analysis demonstrated a significant association of the APD-only group with CRP, and sRAGE demonstrated greatest significance with both the EPD-only and the combined APD-EPD groups.
Interpretation
Among current and former smokers, individuals in the highest 2 deciles for mortality risk on the airway-predominant axis and the emphysema-predominant axis have unique associations to spirometric patterns, different imaging characteristics, biomarkers and causal mortality.